interface language
English
Français
content language
All
English
Français
countries
World
United States
United Kingdom
Canada
Australia
South Africa
Israel
India
France
Belgium
Switzerland
Head Study
Painting by Hans Best
More
24 articles (0.01 seconds)
U.S. investors, Big Pharma race to find new medicines in China
2 months ago
U.S. investors and large pharmaceutical companies are increasingly doing deals in China as the country's biopharma sector transforms.
Business
www.cnbc.com
Innophos Presents Results of New In Vitro Study on Chelated Minerals at SupplySide West 2024
6 months ago
Innophos, a global leader in specialty ingredient solutions for the food, health, and nutrition industries, is exhibiting at SupplySide West (SSW) in Las...
www.prweb.com
Compressing your eating day is as effective as counting calories, study finds
2 years ago
A study that pitted time-restricted eating against a caloric restriction diet found they were equally effective at helping obese people lose weight.
www.latimes.com
'Paradigm Shift': Luspatercept for MDS
2 years ago
Luspatercept showed significant improvement over erythropoiesis-stimulating agent epoetin alfa in reducing dependency on red blood cell transfusions in patients with LR-MDS who are ESA naive.
Health
www.medscape.com
Top-Line Results Positive for Lilly's Oral GLP-1 Orforglipron
4 days ago
The first small-molecule glucagon-like peptide 1 receptor agonist to complete a phase 3 trial lowers A1c and reduces weight, the company says.
Health
www.medscape.com
Significant Improvement in Psoriasis Observed With Novel Oral Drug Icotrokinra, in Phase 3 Trial
a month ago
Adults taking the novel once-daily oral pill for plaque psoriasis have significantly higher rates of clear or almost clear skin, according to an interim analysis of a phase 3 trial.
Health
www.medscape.com
Diabetes patients recruited to answer whether blood sugar monitors are worth it
a year ago
Clinic trial in Minnesota evaluates whether pricy glucose monitors pay off compared with old-school finger-stick tests.
www.startribune.com
IV Secukinumab Trials Hit Primary Endpoints in PsA, AxSpA
a year ago
Two phase 3 trials of the recently approved IV formulation of secukinumab showed its efficacy vs placebo in treating psoriatic arthritis and axial spondyloarthritis.
Health
www.medscape.com
Monoclonal Antibody Reduced Need For Transfusions in Low-Risk MDS
2 years ago
Results suggest a 'paradigm shift' in the treatment of anemia for these patients
Health
www.medpagetoday.com
Rare portrait of Princess Diana sells for more than $200,000
3 years ago
A portrait by Nelson Shanks of Diana, Princess of Wales, sold for $201,600 — more than 10 times its highest estimate of $20,000, according to Sotheby's.
Entertainment
www.today.com
Risankizumab Tops Competitor for Clinical Remission in Moderate-to-Severe CD
2 months ago
Biologic went head to head against ustekinumab in SEQUENCE trial
Health
www.medpagetoday.com
Moderna to scale down manufacturing of COVID vaccine
2 years ago
(Reuters) -Moderna on Wednesday announced it was scaling down manufacturing of its COVID-19 vaccine, an updated version of which was approved this week by...
news.yahoo.com
'The Field in General Sucks': What We Heard This Week
2 years ago
Quotable quotes heard by MedPage Today's reporters
Health
www.medpagetoday.com
A New Era: Intelligent Tutoring Systems Will Transform Online Learning for Millions
3 years ago
Despite artificial intelligence (AI) having transformed major aspects of our society, less than a fraction of its potential has been explored, let alone deployed, for education. AI-powered learning can provide millions of learners with a highly personalized, active and practical learning experience, which is key to successful learning. This is especially relevant in the context of online learning platforms. In this…
Science & Technology
arxiv.org
Eli Lilly says Zepbound beat rival weight loss drug Wegovy in head-to-head study
5 months ago
Zepbound was 47% more effective than its GLP-1 class rival, a Lilly-funded trial found
qz.com
Trial Halted for Bleeding Reduction With Abelacimab vs Rivaroxaban in AF
2 years ago
The phase 2 AZALEA-TIMI 71 trial in AF shows "an overwhelming reduction" in major and clinically relevant nonmajor bleeding with investigational Factor XI inhibitor abelacimab vs rivaroxaban.
Health
www.medscape.com
Long-Acting ART Effective Without Viral Suppression
2 years ago
The latest research on long-acting ART shows benefits even among the unsuppressed; meanwhile, early proof-of-concept results on a twice-yearly injection raise hopes.
Health
www.medscape.com
New Test That Detects 14 Cancers Focuses on Sugars, Not DNA
2 years ago
A new, multi-cancer early detection test is able to detect 14 cancer types based on the analysis of glycosaminoglycans, which change at the earliest stages of cancer.
Health
www.medscape.com
Novel IL-6 Blocker Matches Humira in Rheumatoid Arthritis
3 years ago
But is Russian backing a problem for U.S. approval?
Health
www.medpagetoday.com
Rare portrait of Diana, Princess of Wales, sells for more than $200,000
3 years ago
A rare portrait of Diana, Princess of Wales, sold for more than $200,000 Thursday, fetching ten times its high estimate, according to Sotheby's.
Entertainment
www.nbcnews.com
Previous
Next